CD47 and glioblastoma: The yield of anti-CD47 antibody from OV-αCD47-G1- and OV-αCD47-G4-infected U251T2 GBM cells were quantified by enzyme-linked immunosorbent assay (ELISA), using corresponding antibodies purified from CHO cells with known concentrations as standards.